Stifel analyst Joesph DeNardi double downgraded Hawaiian Holdings (HA) to Sell from Buy and cut its price target to $20 from $30 citing 2020 earnings risk. DeNardi sees downside to 2020 consensus earnings estimates due to declining PRASM results starting in 2020 and Southwest's (LUV) announced additional capacity to Hawaii, which will likely lead to further market share losses.

Catch up on today's top five analyst downgrades with this list compiled by The Fly: 1. Cree (CREE) downgraded to Market Perform from Outperform at JMP Securities with analyst Joseph Osha saying the company has forecasted soft business conditions to persist into the quarter. 2. Hawaiian Holdings (HA) double downgraded to Sell from Buy at Stifel with analyst Joesph DeNardi citing 2020 earnings risk. 3. Chimera (CIM) downgraded to Neutral from Outperform at Credit Suisse with analyst Douglas Harter citing valuation. 4. Synlogic (SYBX) downgraded to Sell from Buy at Citi and to Perform from Outperform at Oppenheimer. 5. Jazz Pharmaceuticals (JAZZ) downgraded to Neutral from Overweight at Piper Jaffray with analyst David Amsellem citing his survey of 30 current prescribers of Xyrem in order to gauge whether there will be physician appetite for using recently approved Wakix, either in replacement or in combination. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.